Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Investigation of a Mycobacterium fortuitum catheter-related bloodstream infection in an oncology unit

PROVIDER: PRJNA843029 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR19429979_1.fastq.gz	Fastqsanger.gz
	SRR19429979_2.fastq.gz	Fastqsanger.gz
	SRR19429980_1.fastq.gz	Fastqsanger.gz
	SRR19429980_2.fastq.gz	Fastqsanger.gz
	SRR19429981_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 6

Similar Datasets

Proteome analysis of Mycobacterium fortuitum biofilm

Project description:Biofilm formation by the environmental and clinical contaminant Mycobacterium fortuitum causes economic losses and serious threat to human health, as a consequence of its increasing contribution to nosocomial infections. There are no reports that elucidate physiological adaptations taking place during its planktonic to biofilm transition. The present study was hence carried out considering the global proteome of the mycobacterium. This is the first description of a global proteomic investigation into M. fortuitum biofilm. Scrutiny of biological functions in the two states provided insights into the phenotypic switch, and fundamental pathways associated with M. fortuitum pathobiology.

2023-09-11 | PXD023784 | Pride

An alveolus lung on a chip model of Mycobacterium fortuitum lung infection

Project description:Lung disease due to non-tuberculous mycobacteria (NTM) is rising in incidence. While both 2D cell culture and animal models exist for NTM infections, a major knowledge gap is the early responses of human alveolar and innate immune cells to NTM within the human lung microenvironment. Here we describe development of a humanized, 3D, alveolus lung-on-a-chip (ALoC) model of Mycobacterium fortuitum infection that incorporates only primary human cells such as pulmonary vascular endothelial cells in a vascular channel, and type I and II alveolar cells and monocyte-derived macrophages in an alveolar channel along an air-liquid interface. M. fortuitum introduced into the alveolar channel primarily infected macrophages, with rare bacteria inside alveolar cells. Bulk-RNA sequencing of infected chips revealed marked upregulation of transcripts for cytokines, chemokines and secreted protease inhibitors (SERPINs). Our results demonstrate how a humanized ALoC system can identify critical early immune and epithelial responses to M. fortuitum infection. We envision potential application of the ALoC to other NTM and for studies of new antibiotics

2024-09-18 | GSE276053 | GEO

Mycolicibacterium fortuitum

Project description:Mycobacterium fortuitum overview

| PRJNA171715 | ENA

Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection

Project description:RATIONALE: Heparin or M-EDTA may prevent catheter-related infections and blockages in patients at high risk for a catheter-related infection. It is not yet known whether heparin is more effective than M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection. PURPOSE: This randomized clinical trial is studying heparin to see how well it works compared with M-EDTA in preventing catheter-related infections and blockages in patients at high risk for a catheter-related infection.

| 2032872 | ecrin-mdr-crc

In vitro and in vivo efficacy of meropenem/vaborbactam against carbapenem-resistant Klebsiella pneumoniae in catheter-related bloodstream infections from an oncology setting.

Project description:In vitro and in vivo efficacy of meropenem/vaborbactam against carbapenem-resistant Klebsiella pneumoniae in catheter-related bloodstream infections from an oncology setting

| PRJEB88190 | ENA

Data-dependent acquisition based proteomic analysis of Mycobacterium fortuitum ATCC 6841

Project description:Detection of species-specific proteotypic peptides for accurate and easy characterization of infectious non-tuberculous mycobacteria such as Mycobacterium fortuitum is essential. Therefore, we carried out an in-depth global proteomic experiment using M. fortuitum ATCC 6841 strain followed by a proteome database search and spectral library generation. The lysate was subjected to in-solution proteomic sample preparation and fractionated using an offline C18 StageTip. Each fraction was acquired in technical triplicates using a 180 min data-dependent acquisition (DDA) method in Orbitrap Fusion Tribrid (Thermo Scientific) mass spectrometer. The resulting raw DDA data were searched against the M. fortuitum proteome database using Proteome Discoverer and FragPipe. The resulting peptide spectrum matches were converted into a spectral library using BiblioSpec.

2024-03-07 | PXD040567 | Pride

Mycobacterium fortuitum ATCC 6841

Project description:Mycobacterium fortuitum ATCC 6841 genome

| PRJEB9497 | ENA

Project description:Complete genome sequence of Staphylococcus condimenti isolated from a port catheter-associated bloodstream infection.

| PRJNA936100 | ENA

Mycolicibacterium fortuitum strain:CT6

Project description:Mycobacterium fortuitum genome sequencing and assembly

| PRJNA280545 | ENA

An alveolus lung on a chip model of Mycobacterium fortuitum lung infection

Project description:An alveolus lung on a chip model of Mycobacterium fortuitum lung infection

| PRJNA1154596 | ENA